维普期刊资源整合服务平台（V6.5）

99篇 您的检索式：作者名="BAER MR"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Signal transducer and activator of transcription proteins in leukemias显示文摘	Benekli M Baer MR Baumann H	2013	{H}Blood2013，，05：	1
2	Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes:the alternative dosing for outpatient treatment (ADOPT)trial显示文摘	Steensma DP Baer MR Slack JL	2009	J Clin Oncol2009，27，23：	1
3	Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes:the alternative dosing for outpatient treatment (ADOPT) trial显示文摘	Steensma DP Baer MR Slack JL	2009	J Clin Oncol2009，27，23：	1
4	Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemia 显示文摘	BAER MR BERNSTEIN SH BRUNETTO VL	1996	Blood1996，87，4：	1
5	Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial 显示文摘	Steensma DP Baer MR Slack JL	2009	J Clin Oncol2009，27，23：	1
6	Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes; the alternative dosing for outpatient treatment (ADOPT) trial显示文摘	Steensma DP Baer MR Slack JL	2009	J Clin Oncol2009，27，23：	1
7	Signal transducer and activator of transcription proteins in leukemias显示文摘	Benekli M Baer MR Baumann H et at	2003	Blood2003，101，8：	1
8	Signal transducer and activator of transcription proteins in leukemias 显示文摘	Benekli M Baer MR Baumann H	2003	Blood2003，101，8：	1
9	Acute myeloid leukemia clinical practice guidelines in oncology显示文摘	O′Donnell MR Appelbaum FR Baer MR	2006	J Natl Compr Canc Netw2006，4，1：	1
10	Multicenter study of deeitabine administered daily for 5 days every 4 weeks to adults with myelodysplastie syndromes:the al- ternative dosing for outpatient treatment(ADOPT)trial 显示文摘	Steensma DP Baer MR Slack JL	2009	Journal of Clinical Oneology Official Journal of the Ameriean Society of Clinical Oneology2009，27，23：	1
11	Role of breast cancer resistance protein (BCRP/ ABCG2) in cancer drug resistance显示文摘	NATARAJAN K XIE Y BAER MR		0，，08：	1
12	Glut-3 expression in biopsy specimens of laryngeal carcinoma is associated withpoor survival显示文摘	Baer S Casaubon L Schwartz MR Marcogliese A Younes M	2002	Laryngoscope2002，112，2：	1
13	Low-dose Interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720 显示文摘	Baer MR George SL Caligiuri MA	2008	J Clin Oncol2008，26，30：	1
14	Multicenter study of decitabine administered daily for 5 days every 4 weeks to adultswith myelodysplastie syndromes: the alternative dosing for outpatient treatment( ADOPT ) trial 显示文摘	SteensmaDP Baer MR Slack JL	2009	JClinOncol2009，27，23：	1
15	Acute myelid leukemia clinical practice guidelines in oncology 显示文摘	O'Donnell MR Appelbaum FR Baer MR	2006	J Natl Compr Canc Netw2006，4，1：	1
16	Signal transducer and activator of transcription proteins in leukemias 显示文摘	Benekli M Baer MR Baumann H	2003	Blood2003，101，8：	1
17	P53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia 显示文摘	Link PA Baer MR James SR	2008	Cancer Res2008，68，：	1
18	Expression of c-mpl mRNA,the receptor for thrombopoictin,in acute myeloid leu- kemia blasts identifies a group of patients wlt0 poor response to intensive chemotherapy显示文摘	Wetzler M Baer MR Bernstein SH	1997	J Clin Oncol1997，15，6：	1
19	Multieenter study of decit- abine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial显示文摘	Steensma DP Baer MR Slack JL	2009	J Clin Oncol2009，27，23：	1
20	Muhicenter study of decitabine a&ninistered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial 显示文摘	Steensma DP Baer MR Slack JL	2009	J Clin Oncol2009，27，23：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示